Prostate cancer: Relationship between vascular diameter, shape and density and Gleason score in needle biopsy specimens
- PMID: 23930248
- PMCID: PMC3732884
- DOI: 10.4103/2277-9175.107963
Prostate cancer: Relationship between vascular diameter, shape and density and Gleason score in needle biopsy specimens
Abstract
Background: Tumor growth requires expansion and development of vascular network. An increase in Gleason score is representative of an increase in tumor invasion and extent. In this study, the relationship between Gleason score and vascular characteristics of needle biopsy samples in prostate cancer patients has been evaluated.
Materials and methods: We evaluated vascular characteristics including density and size of vessels; and percentage of vessels with irregular shape in 62 cancer-positive samples obtained by prostate needle biopsy under ultrasound guide, and compared them to Gleason score.
Result: Gleason scores of 23 patients were ≤6; Gleason scores of 18 patients were 7 and 21 patients had their Gleason score from 8 to 10. An increase in Gleason score was associated with increased vascular density (P < 0.0001), increased percentage of vessels with irregular shape (P < 0.02) and decreased average vascular diameter (P < 0.015), from which the relationship with vascular density was clearer and more evident.
Conclusion: Vascular morphological characteristics can be representative of angiogenic potential of prostate cancer which is required for tumor progression. As Gleason score can prognosticate the behavioral characteristics of prostate cancer in future, vascular characteristics may also be able to express tumor behavior. With attention to vascular characteristics in biopsy samples and apart from Gleason score, we may also be able to divide patients into other subtypes in a way being helpful for the establishment of treatment plan.
Keywords: Gleason score; prostate cancer; vessel density.
Conflict of interest statement
Similar articles
-
Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy.J Urol. 2003 Jan;169(1):136-40. doi: 10.1016/S0022-5347(05)64053-0. J Urol. 2003. PMID: 12478121
-
Correlation of Gleason scores between needle-core biopsy and radical prostatectomy specimens in patients with prostate cancer.J Chin Med Assoc. 2005 Apr;68(4):167-71. doi: 10.1016/S1726-4901(09)70243-6. J Chin Med Assoc. 2005. PMID: 15850066
-
Significance of small foci of Gleason score 7 or greater prostate cancer on needle biopsy.Urology. 1999 Sep;54(3):528-32. doi: 10.1016/s0090-4295(99)00166-1. Urology. 1999. PMID: 10475366
-
Discrepancy between Gleason scores of biopsy and radical prostatectomy specimens.Eur Urol. 2000 Jun;37(6):670-4. doi: 10.1159/000020216. Eur Urol. 2000. PMID: 10828666 Review.
-
An update of the Gleason grading system.J Urol. 2010 Feb;183(2):433-40. doi: 10.1016/j.juro.2009.10.046. Epub 2009 Dec 14. J Urol. 2010. PMID: 20006878 Review.
Cited by
-
Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy.Cancers (Basel). 2022 Sep 15;14(18):4475. doi: 10.3390/cancers14184475. Cancers (Basel). 2022. PMID: 36139635 Free PMC article.
-
Sirtuin 5 regulates the proliferation, invasion and migration of prostate cancer cells through acetyl-CoA acetyltransferase 1.J Cell Mol Med. 2020 Dec;24(23):14039-14049. doi: 10.1111/jcmm.16016. Epub 2020 Oct 26. J Cell Mol Med. 2020. PMID: 33103371 Free PMC article.
-
Synthesis and characterization of polystyrene embolization particles doped with tantalum oxide nanoparticles for X-ray contrast.J Mater Sci Mater Med. 2015 Aug;26(8):218. doi: 10.1007/s10856-015-5549-5. Epub 2015 Jul 30. J Mater Sci Mater Med. 2015. PMID: 26223792
-
Correlation between microvessel maturity and ISUP grades assessed using contrast-enhanced transrectal ultrasonography in prostate cancer.Open Med (Wars). 2023 Aug 9;18(1):20230772. doi: 10.1515/med-2023-0772. eCollection 2023. Open Med (Wars). 2023. PMID: 37588658 Free PMC article.
-
Ultrasound super-resolution imaging for non-invasive assessment of microvessel in prostate lesion.Cancer Imaging. 2025 Jan 7;25(1):1. doi: 10.1186/s40644-024-00819-z. Cancer Imaging. 2025. PMID: 39773358 Free PMC article.
References
-
- Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005;293:2095–101. - PubMed
-
- Johansson JE, Andrén O, Andersson SO, Dickman PW, Holmberg L, Magnuson A, et al. Natural history of early, localized prostate cancer. JAMA. 2004;291:2713–9. - PubMed
-
- Bill-Axelson A, Holmberg L, Ruutu M, Häggman M, Andersson SO, Bratell S, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005;352:1977–84. - PubMed
-
- Porter CR, Kodama K, Gibbons RP, Correa R, Jr, Chun FK, Perrotte P, et al. 25-year prostate cancer control and survival outcomes: A 40-year radical prostatectomy single institution series. J Urol. 2006;176:569–74. - PubMed
-
- William J Catalona, Misop Han. Defnitive Therapy for localized prostate cancer: An overview. In: Alan J Wein., editor. Campbell-Walsh Urology. New York: McGraw-Hill; 2012. pp. 2772–85.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials